These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Effectiveness of RSVIG prophylaxis and therapy of respiratory syncytial virus in an immunosuppressed animal model. Ottolini MG; Porter DD; Hemming VG; Zimmerman MN; Schwab NM; Prince GA Bone Marrow Transplant; 1999 Jul; 24(1):41-5. PubMed ID: 10435733 [TBL] [Abstract][Full Text] [Related]
6. Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections. American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn Pediatrics; 2003 Dec; 112(6 Pt 1):1442-6. PubMed ID: 14654627 [TBL] [Abstract][Full Text] [Related]
7. Immunoprophylaxis of group B respiratory syncytial virus infection in cotton rats. Faverio LA; Piazza FM; Johnson SA; Darnell ME; Ottolini MG; Hemming VG; Prince GA J Infect Dis; 1997 Apr; 175(4):932-4. PubMed ID: 9086152 [TBL] [Abstract][Full Text] [Related]
8. A dose-ranging study of a subunit Respiratory Syncytial Virus subtype A vaccine with and without aluminum phosphate adjuvantation in adults > or =65 years of age. Langley JM; Sales V; McGeer A; Guasparini R; Predy G; Meekison W; Li M; Capellan J; Wang E Vaccine; 2009 Sep; 27(42):5913-9. PubMed ID: 19651171 [TBL] [Abstract][Full Text] [Related]
9. Systemic immunoprophylaxis of nasal respiratory syncytial virus infection in cotton rats. Sami IR; Piazza FM; Johnson SA; Darnell ME; Ottolini MG; Hemming VG; Prince GA J Infect Dis; 1995 Feb; 171(2):440-3. PubMed ID: 7844385 [TBL] [Abstract][Full Text] [Related]
10. Humoral and mucosal immunity in protection from natural respiratory syncytial virus infection in adults. Walsh EE; Falsey AR J Infect Dis; 2004 Jul; 190(2):373-8. PubMed ID: 15216475 [TBL] [Abstract][Full Text] [Related]
11. Respiratory syncytial virus infection in patients with hematological diseases: single-center study and review of the literature. Khanna N; Widmer AF; Decker M; Steffen I; Halter J; Heim D; Weisser M; Gratwohl A; Fluckiger U; Hirsch HH Clin Infect Dis; 2008 Feb; 46(3):402-12. PubMed ID: 18181739 [TBL] [Abstract][Full Text] [Related]
12. Role of antibody and use of respiratory syncytial virus (RSV) immune globulin to prevent severe RSV disease in high-risk children. Groothuis JR J Pediatr; 1994 May; 124(5 Pt 2):S28-32. PubMed ID: 8169755 [TBL] [Abstract][Full Text] [Related]
14. Serum neutralizing antibody titers of seropositive chimpanzees immunized with vaccines coformulated with natural fusion and attachment proteins of respiratory syncytial virus. Hancock GE; Smith JD; Heers KM J Infect Dis; 2000 May; 181(5):1768-71. PubMed ID: 10823781 [TBL] [Abstract][Full Text] [Related]
15. Induction of mucosal B-cell memory by intranasal immunization of mice with respiratory syncytial virus. Valosky J; Hishiki H; Zaoutis TE; Coffin SE Clin Diagn Lab Immunol; 2005 Jan; 12(1):171-9. PubMed ID: 15643003 [TBL] [Abstract][Full Text] [Related]
16. Respiratory syncytial virus-enriched globulin for the prevention of acute otitis media in high risk children. Simoes EA; Groothuis JR; Tristram DA; Allessi K; Lehr MV; Siber GR; Welliver RC J Pediatr; 1996 Aug; 129(2):214-9. PubMed ID: 8765618 [TBL] [Abstract][Full Text] [Related]
17. Alphavirus replicon particles encoding the fusion or attachment glycoproteins of respiratory syncytial virus elicit protective immune responses in BALB/c mice and functional serum antibodies in rhesus macaques. Elliott MB; Chen T; Terio NB; Chong SY; Abdullah R; Luckay A; Egan MA; Boutilier LA; Melville K; Lerch RA; Long D; Eldridge JH; Parks CL; Udem SA; Hancock GE Vaccine; 2007 Oct; 25(41):7132-44. PubMed ID: 17850933 [TBL] [Abstract][Full Text] [Related]
18. Intranasal immunization with a replication-deficient adenoviral vector expressing the fusion glycoprotein of respiratory syncytial virus elicits protective immunity in BALB/c mice. Fu Y; He J; Zheng X; Wu Q; Zhang M; Wang X; Wang Y; Xie C; Tang Q; Wei W; Wang M; Song J; Qu J; Zhang Y; Wang X; Hong T Biochem Biophys Res Commun; 2009 Apr; 381(4):528-32. PubMed ID: 19233131 [TBL] [Abstract][Full Text] [Related]
19. Ultra-potent antibodies against respiratory syncytial virus: effects of binding kinetics and binding valence on viral neutralization. Wu H; Pfarr DS; Tang Y; An LL; Patel NK; Watkins JD; Huse WD; Kiener PA; Young JF J Mol Biol; 2005 Jul; 350(1):126-44. PubMed ID: 15907931 [TBL] [Abstract][Full Text] [Related]
20. [Plasmid construction, expression, immunogenicity and protective efficacy of recombinant protein candidate vaccine of respiratory syncytial virus]. Zeng RH; Gong W; Fang XP; Zhang ZY; Mei XG Sheng Wu Gong Cheng Xue Bao; 2005 Jul; 21(4):534-9. PubMed ID: 16176088 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]